New results from a U.S. patient survey revealed that people living with metastatic colorectal cancer (#mCRC) need more clear and accessible information at initial diagnosis.? ? Read more about the informational and support gaps uncovered in the survey, conducted in collaboration with BLKHLTH, Family Reach, COLONTOWN and Colorectal Cancer Alliance: https://lnkd.in/gcZKptnD #CRC #crcsm.? ? These data were presented at this year’s Association of Cancer Care Centers (ACCC) Congress.
关于我们
Takeda Oncology, the Global Oncology Business Unit of Takeda Pharmaceutical Company Limited, is structured to ensure a tight connection from research to development to commercialization and rapidly meet the needs of the cancer community, optimizing our ability to bring transformative medicines to market. Built on a legacy foundation and structured for agility, our leaders have proven experience to drive future growth. We’ve demonstrated leadership in the treatment of hematologic cancers and solid tumors, and we’re now leveraging that expertise to advance cutting-edge science through multiple platforms, partnerships and therapeutic approaches. We are focused on collaborating with leading scientific teams around the globe to accelerate remarkable innovation, including by leveraging the power of innate immunity to enhance and broaden the impact of immunotherapy. We complement our deep in-house expertise with a network of symbiotic external partnerships to unlock the most promising science wherever it emerges. We fuel our relationships with academic, biotechnology and pharmaceutical partners with mutual respect, shared knowledge, scientific rigor and agility to find the best way to attack cancer. Takeda Oncology: We aspire to cure cancer, with inspiration from patients and innovation from everywhere. For more information, visit www.takedaoncology.com. If you are interested in learning more about current career opportunities, please visit the Takeda Pharmaceuticals Career Page. Review our social media community guidelines: https://www.takedaoncology.com/social-media-policy/
- 网站
-
https://www.takedaoncology.com
Takeda Oncology的外部链接
- 所属行业
- 制药业
- 规模
- 1,001-5,000 人
- 总部
- Cambridge，MA
- 类型
- 上市公司
- 创立
- 1993
- 领域
- oncology、drug development和biotechnology
地点
-
主要
获取路线
40 Landsdowne St.
US，MA，Cambridge，02139
Takeda Oncology员工
动态
-
Results from a new U.S. patient survey reveal the impact of metastatic colorectal cancer (#mCRC) on patient health-related quality of life.?? ? The survey, conducted in collaboration with BLKHLTH, Family Reach, COLONTOWN and Colorectal Cancer Alliance, seeks to uncover actionable insights that will help guide the collective development of resources and education to support patients.? ? Read the full results that were presented at this year’s American Society of Clinical Oncology (ASCO)’s Quality Care Symposium: https://lnkd.in/enGqY4_D #CRC #crcsm?
-
Leaders like?PK inspire all of us to continue moving forward in our aspiration to cure cancer. Find out more about?our own Phuong Khanh (PK) Morrow, Head, Oncology Therapeutic Area Unit,?and how her approach to pushing boundaries and leading with kindness has shaped her career in an interview with?Authority Magazine.
Innovative leader who is passionate about developing impactful medicines for serious human diseases
From my early days as an oncologist to my current role in medicine, my passion has always been to improve care for people living with #cancer. My career journey has enabled me to have the honor of leading teams accelerating the development and delivery of cancer medicines to address the urgent needs of patients on a global scale. I recently had the opportunity to speak with Authority Magazine about career highlights to date and how they have impacted how I approach my role and the mentorship of others. Despite the challenges I have encountered along the way, I’m more motivated than ever to continue pushing the boundaries of what is possible and to help support the next generation of leaders in the fight against cancer! Read our full discussion:
-
Next week, we’ll be joining the?#HEOR?community in Barcelona, Spain at #ISPOREurope! In addition to convening with other experts in #oncology, we look forward to sharing insights on the latest trends in health economics and outcomes research. Check out the workshop and the poster sessions that Luis Hernandez, Head, Global Health Economics & US HEOR, Oncology, and Victoria Federico Paly, Lead, Global Health Economics, Oncology, will lead at the conference:? ? ???Contextualizing uncertainty in #EUHTA #JCA submissions, coming to terms with imperfect data - Workshop? ???Navigating the new Quantitative Evidence Synthesis Guidelines from the EU Member State Coordination Group on #HTA - Top 5% Poster? ???Landscape assessment and comparison of HTA guidance on patient reported outcome measures #PROMs - Top 5% Poster? ???Cost-effectiveness analysis in newly diagnosed #HodgkinLymphoma - Top 5% Poster? ???The survival benefit and the impact on patients’ quality of life of adverse events associated systemic therapies for #mCRC? ???Cost implications of red blood cell and platelet transfusions in EU and North America We hope to see you there! Learn more:?https://lnkd.in/ejHyHMbN?
-
-
As the #oncology industry?adjusts to evolving policies,?creative solutions are on the horizon. Whether it be through collaboration,?or leveraging?new tech and?#AI, it’s crucial we adapt our approach to?continue meeting the needs of people living with #cancer?and?ensuring?access to?new and existing?medications. Our own Liz Lewis, Head, Global Oncology Pricing, Value and Access, recently shared?her thoughts?on the changing policy landscape?with Pharmaceutical Executive. Read the full article below.
How can we?adapt our #oncology drug development strategies to?abide by?evolving?regulatory?guidelines while efficiently meeting patient needs??As we continue to?adapt?our approach, there are new challenges and opportunities to explore that are crucial for improving patient care globally. Read my thoughts on how Takeda Oncology?is driving innovation amidst?change in?the article below?from?Pharmaceutical Executive: https://lnkd.in/eEAEsf6T
Solving One of the Hardest Questions in Cancer: How Do We Ensure Patient Access to Medicines?
pharmexec.com
-
We are always proud to be a National Sponsor of?The Leukemia & Lymphoma Society's?Light the?Night?Walk. Recently, #TeamTakeda joined hundreds of families, care partners and many others in?the?blood #cancer community on?the?Boston Common to raise awareness and bring hope for a brighter future without cancer. #LightTheNight?
-
-
Achieving our aspiration to cure #cancer requires close collaboration both?internally and with those beyond the walls of Takeda. By working together as a collective #oncology ecosystem, we can more effectively address the needs of people living with cancer.?View Pallavi Garg’s interview with PhRMA,?in which she discusses the transformative promise of partnerships: https://lnkd.in/enVrcQJW
-
Today at BioTechX EU, our own Philipp Pauli, Country Head Germany, and other industry leaders led a panel discussion about the role of?Big Data in #oncology.?Thanks to the innovative work of people like Philipp, #TeamTakeda continues to make advancements in predictive analytics, using big data to forecast disease progression and treatment responses to help improve the patient experience. #BioTechX
Happy to share I have been hosting today’s track Big Data in Oncology at @BioTechX EU 24 conference https://lnkd.in/eAUPUKz9. Together with so many inspiring speakers we took a closer look at data-driven Oncology and how AI aims to transform precision oncology, clinical studies and personalized therapies. Honor to chair this amazing track and many thanks to all speakers involved here! #BioTechX #BigDataInOncology Thomas Hufener Christophe Dufour Georgia Chan Jean-Pierre Hubaux Jacob Reimers Jon Teague Shayoni Dutta Mieke Van Hemelrijck Mike Rossi Karl Smith Byrne
-
-
This #BloodCancerAwarenessMonth, #TeamTakeda wore red in solidarity with the #BloodCancer community. Swipe to see how our team put blood cancer awareness in the spotlight to call attention to the urgent need for more action.
-
-
Next month, our own?Philipp Pauli, Country Head Germany, will host the Big Data in Oncology panel discussion during the?BioTechX?EU conference on October 9th in Basel, Switzerland. Want to hear Philipp’s thoughts on?big?data and the latest in multiomic data management and personalized therapies?ahead of the conference? Read his interview here:?https://lnkd.in/e6CUHjeZ?#BioTechX #BigDataInOncology
-